ASRS
SNDX icon

Arizona State Retirement System’s Syndax Pharmaceuticals SNDX Stock Holding History

Arizona State Retirement System’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
23,120
+642
+3% +$13.4K ﹤0.01% 1531
2026
Q1 		$525K Sell
22,478
-335
-1% -$7.28K ﹤0.01% 1431
2025
Q4 		$479K Sell
22,813
-1,345
-6% -$23.5K ﹤0.01% 1506
2025
Q3 		$372K Sell
24,158
-929
-4% -$12.2K ﹤0.01% 1676
2025
Q2 		$235K Buy
25,087
+3,080
+14% +$33.9K ﹤0.01% 1839
2025
Q1 		$270K Sell
22,007
-220
-1% -$3.1K ﹤0.01% 1739
2024
Q4 		$294K Buy
22,227
+202
+0.9% +$3.46K ﹤0.01% 1769
2024
Q3 		$424K Buy
22,025
+618
+3% +$12.8K ﹤0.01% 1573
2024
Q2 		$439K Buy
21,407
+430
+2% +$9K ﹤0.01% 1503
2024
Q1 		$499K Buy
20,977
+4,466
+27% +$99.6K ﹤0.01% 1448
2023
Q4 		$357K Buy
16,511
+835
+5% +$12.8K ﹤0.01% 1638
2023
Q3 		$228K Buy
15,676
+285
+2% +$5.39K ﹤0.01% 1833
2023
Q2 		$322K Sell
15,391
-149
-1% -$3.1K ﹤0.01% 1672
2023
Q1 		$328K Buy
15,540
+1,973
+15% +$49.1K ﹤0.01% 1657
2022
Q4 		$345K Buy
13,567
+578
+4% +$13.5K ﹤0.01% 1599
2022
Q3 		$312K Buy
12,989
+884
+7% +$19.8K ﹤0.01% 1611
2022
Q2 		$233K Buy
12,105
+1,424
+13% +$23.7K ﹤0.01% 1839
2022
Q1 		$186K Buy
10,681
+211
+2% +$3.55K ﹤0.01% 2038
2021
Q4 		$229K Sell
10,470
-44
-0.4% -$813 ﹤0.01% 2011
2021
Q3 		$201K Buy
10,514
+267
+3% +$4.45K ﹤0.01% 2076
2021
Q2 		$176K Buy
10,247
+812
+9% +$14.9K ﹤0.01% 2145
2021
Q1 		$211K Buy
+9,435
New +$213K ﹤0.01% 2014

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Arizona State Retirement System's SNDX Position: Q2 2026 in Review

Arizona State Retirement System increased its Syndax Pharmaceuticals (SNDX) stake by 2.9% in Q2 2026, buying an estimated $13.4K and bringing the position to 23,120 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Arizona State Retirement System first reported a position in SNDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $525K in Q1 2026. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Arizona State Retirement System held 23,120 shares of Syndax Pharmaceuticals worth $505K as of Q2 2026.
  • Arizona State Retirement System bought 642 Syndax Pharmaceuticals shares in Q2 2026, an estimated $13.4K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1531 holding.
  • Arizona State Retirement System first reported a position in Syndax Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Arizona State Retirement System's Syndax Pharmaceuticals position peaked at $525K in Q1 2026.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.